Dr. Kowthar Salim, Mba, Phd
Vice President
Development
Critical Outcome Technologies
Canada
Biography
Dr. Salim directs multi-disciplinary R&D teams of contract research organizations to bring new product candidates from target validation to IND filing and clinical trials to fill and advance COTI’s pipeline of drug candidates. She provides strategic planning, coordination, and scientific leadership throughout COTI’s product development activities in multiple functional areas such as manufacturing, pharmacology, pharmacokinetics, toxicology, and clinical development and operations. Dr. Salim led the team that successfully obtained FDA approval for COTI’s first IND application. Dr. Salim earned her PhD in Molecular Genetics and Microbiology from the University of Toronto in 2007, and her MBA in Management of Technology and Innovation from Ryerson University in 2013. Prior to joining COTI in 2008, she was a consultant with GeneEx Inc., and a research associate at the University of Toronto where she facilitated commercialization of the technology discovered during her doctoral studies. Dr. Salim is named as an inventor on patents and her research resulted in several publications.
Research Interest
clinical development and operations
